IXC Ann: German Approval for IIH EVOLVE Phase 3 Clinical Trial - 20th Mar 2023, 8:11am

annb0t

annb0t

Top 20
IXC Ann: German Approval for IIH EVOLVE Phase 3 Clinical Trial
Price Sensitive: Y
Date: 20th Mar 2023, 8:11am

>>> Read announcement: Google: IXC Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
IXC Ann: Notification of cessation of securities - IXC - 20th Oct 2023, 10:30am
Replies
0
Views
68
annb0t
annb0t
annb0t
IXC Ann: Notice of Annual General Meeting/Proxy Form - 19th Oct 2023, 3:10pm
Replies
0
Views
62
annb0t
annb0t
annb0t
IXC Ann: Quarterly Activities/Appendix 4C Cash Flow Report - 12th Oct 2023, 3:54pm
Replies
0
Views
56
annb0t
annb0t
annb0t
IXC Ann: Change in substantial holding - 28th Sep 2023, 12:43pm
Replies
0
Views
70
annb0t
annb0t
annb0t
IXC Ann: Date of AGM and Closing Date for Director Nominations - 25th Sep 2023, 4:14pm
Replies
0
Views
87
annb0t
annb0t
Top Bottom